US BANCORP \DE\ - BIOCEPT INC ownership

BIOCEPT INC's ticker is BIOC and the CUSIP is 09072V501. A total of 30 filers reported holding BIOCEPT INC in Q3 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of BIOCEPT INC
ValueSharesWeighting
Q1 2023$198
-35.9%
5830.0%0.00%
Q4 2022$3095830.0%0.00%
Q3 2022$05830.0%0.00%
Q2 2022$0
-100.0%
5830.0%0.00%
Q1 2022$1,000
-50.0%
5830.0%0.00%
Q4 2021$2,0000.0%5830.0%0.00%
Q3 2021$2,0000.0%5830.0%0.00%
Q2 2021$2,000
-33.3%
5830.0%0.00%
Q1 2021$3,000
+50.0%
5830.0%0.00%
Q4 2020$2,000
-33.3%
583
-13.6%
0.00%
Q3 2020$3,0006750.00%
Other shareholders
BIOCEPT INC shareholders Q3 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 29,602$10,0650.01%
Taylor & Morgan Wealth Management, LLC 26,000$8,8400.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 94,200$32,0280.00%
FMR LLC 40$140.00%
US BANCORP \DE\ 583$1980.00%
Focused Wealth Management, Inc 1$00.00%
WELLS FARGO & COMPANY/MN 118$400.00%
JANE STREET GROUP, LLC 25,403$8,6370.00%
NORTHERN TRUST CORP 26,818$9,1180.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BIOCEPT INC shareholders